Non-Immune Hydrops Fetalis: Do Placentomegaly and Polyhydramnios Matter?

OBJECTIVES: Polyhydramnios and placentomegaly are commonly observed in nonimmune hydrops fetalis (NIHF); however, whether their ultrasonographic identification is relevant for prognosis is controversial. We evaluated outcomes of fetal or neonatal death and preterm birth (PTB) in cases of NIHF alone and in those with polyhydramnios and/or placentomegaly (P/PM). METHODS: We conducted a retrospective cohort of singletons with NIHF evaluated between 1994 and 2013. Nonimmune hydrops fetalis was defined as 2 or more abnormal fluid collections, including ascites, pericardial effusion, pleural effusion, and skin edema. Primary outcomes were intrauterine fetal demise (IUFD) and neonatal death. Secondary outcomes were PTB (<37, < 34, and <28 weeks) and spontaneous PTB. Outcomes were compared between cases of NIHF alone and NIHF with P/PM. RESULTS: A total of 153 cases were included; 21% (32 of 153) had NIHF alone, and 79% (121 of 153) had NIHF with P/PM. There was no significant difference in neonatal death (38.1% versus 43.0%; P = .809) between the groups. Intrauterine fetal demise was seen more frequently in NIHF alone (34.4% versus 17.4%; P = .049). Nonimmune hydrops fetalis-with-P/PM cases were more likely to deliver before 37 weeks (80.0% versus 57.1%; P = .045) and before 34 weeks (60.0% versus 28.6%; P = .015) and to have spontaneous PTB (64.4% versus 33.3%; P = .042). Adjusted odds ratios accounting for the etiology of NIHF supported these findings, with the exception of IUFD. CONCLUSIONS: Compared to NIHF alone, pregnancies with NIHF and P/PM had a lower risk of IUFD and were at increased risk of PTB (<37 and <34 weeks) and spontaneous PTB. This information may help providers in counseling patients with NIHF and supports the need for close antenatal surveillance.

Direct and indirect antigen presentation lead to deletion of donor-specific T cells after in utero hematopoietic cell transplantation in mice.

In utero hematopoietic cell transplantation (IUHCTx) is a promising method to induce donor-specific tolerance but the mechanisms of antigen presentation that educate host T cells and the relative importance of deletion vs regulation in this setting are unknown. We studied the roles of direct and indirect antigen presentation (mediated by donor- and host-derived antigen-presenting cells [APCs], respectively) in a mouse model of IUHCTx. We found that IUHCTx leads to precocious maturation of neonatal host dendritic cells (DCs) and that there is early differentiation of donor-derived DCs, even after transplantation of a stem cell source without mature APCs. We next performed allogeneic IUHCTx into donor-specific T-cell receptor transgenic mice and confirmed that both direct and indirect antigen presentation lead to clonal deletion of effector T cells in chimeras. Deletion did not persist when chimerism was lost. Importantly, although the percentage of regulatory T cells (Tregs) after IUHCTx increased, there was no expansion in Treg numbers. In wild-type mice, there was a similar deletion of effector cells without expansion of donor-specific Tregs. Thus, tolerance induction after IUHCTx depends on both direct and indirect antigen presentation and is secondary to thymic deletion, without de novo Treg induction.

Intensive care unit bounce back in trauma patients: an analysis of unplanned returns to the intensive care unit.

BACKGROUND: Discharging patients from the intensive care unit (ICU) often requires complex decision making to balance patient needs with available resources. Unplanned return to the ICU ("bounce back" [BB]) has been associated with increased resource use and worse outcomes, but few data on trauma patients are available. The goal of this study was to review ICU BB and define ICU discharge variables that may be predictive of BB. METHODS: Adults admitted to ICU and discharged alive to a ward from November 04, 2012, to September 9, 2012 (interval with no changes in coverage), were selected from our trauma registry. Patients with unplanned return to ICU (BB cases) were matched 1:2 with controls on age, Injury Severity Score (ISS), and duration of post-ICU stay. Data were collected by chart review then analyzed with univariate and conditional multivariate techniques. RESULTS: Of 8,835 hospital admissions, 1,971 (22.3%) were discharged alive from ICU to a ward. Eighty-eight patients (4.5%) met our criteria for BB (male, 75%; mean [SD] age, 52.9 [21.9] years; mean [SD] ISS, 23.1 [10.2]). Most (71.6%) occurred within 72 hours. Mortality for BB cases was high (19.3%). Regression analysis showed that male sex (odds ratio, 2.9; p = 0.01), Glasgow Coma Scale [GCS] score of less than 9 (odds ratio, 22.3; p < 0.01), discharge during day shift (odds ratio, 6.9; p < 0.0001), and presence of one (odds ratio, 3.5; p = 0.03), two (odds ratio, 3.8; p = 0.03), or three or more comorbidities (odds ratio, 8.4; p < 0.001) were predictive of BB. CONCLUSION: In this study, BB rate was 4.8%, and associated mortality was 19.3%. At the time of ICU discharge, male sex, a GCS score of less than 9, higher FIO2, discharge on day shift, and presence of one or more comorbidities were the strongest predictors of BB. A multi-institutional study is needed to validate and extend these results. LEVEL OF EVIDENCE: Epidemiologic/prognostic study, level IV.